245 related articles for article (PubMed ID: 36206047)
1. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
[TBL] [Abstract][Full Text] [Related]
2. Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy.
Himelman E; Lillo MA; Nouet J; Gonzalez JP; Zhao Q; Xie LH; Li H; Liu T; Wehrens XH; Lampe PD; Fishman GI; Shirokova N; Contreras JE; Fraidenraich D
J Clin Invest; 2020 Apr; 130(4):1713-1727. PubMed ID: 31910160
[TBL] [Abstract][Full Text] [Related]
3. Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers.
Nouet J; Himelman E; Lahey KC; Zhao Q; Fraidenraich D
Sci Rep; 2020 Mar; 10(1):5683. PubMed ID: 32231219
[TBL] [Abstract][Full Text] [Related]
4. Normalization of connexin 43 protein levels prevents cellular and functional signs of dystrophic cardiomyopathy in mice.
Gonzalez JP; Ramachandran J; Himelman E; Badr MA; Kang C; Nouet J; Fefelova N; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
Neuromuscul Disord; 2018 Apr; 28(4):361-372. PubMed ID: 29477453
[TBL] [Abstract][Full Text] [Related]
5. S-nitrosylation of connexin43 hemichannels elicits cardiac stress-induced arrhythmias in Duchenne muscular dystrophy mice.
Lillo MA; Himelman E; Shirokova N; Xie LH; Fraidenraich D; Contreras JE
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751316
[TBL] [Abstract][Full Text] [Related]
6. A role for connexin-43 in Duchenne muscular dystrophy cardiomyopathy.
Shaw RM; Saffitz JE
J Clin Invest; 2020 Apr; 130(4):1608-1610. PubMed ID: 32091412
[TBL] [Abstract][Full Text] [Related]
7. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
8. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
9. Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice.
Gonzalez JP; Ramachandran J; Xie LH; Contreras JE; Fraidenraich D
Sci Rep; 2015 Aug; 5():13490. PubMed ID: 26311238
[TBL] [Abstract][Full Text] [Related]
10. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
Nasilli G; de Waal TM; Marchal GA; Bertoli G; Veldkamp MW; Rothenberg E; Casini S; Remme CA
Cardiovasc Res; 2024 May; 120(7):723-734. PubMed ID: 38395031
[TBL] [Abstract][Full Text] [Related]
11. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
12. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
14. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.
Betts CA; Saleh AF; Carr CA; Hammond SM; Coenen-Stass AM; Godfrey C; McClorey G; Varela MA; Roberts TC; Clarke K; Gait MJ; Wood MJ
Sci Rep; 2015 Mar; 5():8986. PubMed ID: 25758104
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
Oliveira-Santos A; Dagda M; Burkin DJ
Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Kim MJ; Bible KL; Regnier M; Adams ME; Froehner SC; Whitehead NP
Physiol Rep; 2019 Mar; 7(6):e14018. PubMed ID: 30912308
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
19. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
